Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.

Antimicrobial agents and chemotherapy - 1 Aug 2014

Jeddi Fakhri, Mary Charles, Aoun Karim, Harrat Zoubir, Bouratbine Aïda, Faraut Françoise, Benikhlef Rezika, Pomares Christelle, Pratlong Francine, Marty Pierre, Piarroux Renaud

Abstract excerpt

Antimonials remain the first-line treatment for the various manifestations of leishmaniasis in most areas where the disease is endemic, and increasing cases of therapeutic failure associated with parasite resistance have been reported. In this study, we assessed the molecular status of 47 clinical isolates of Leishmania causing visceral and cutaneous leishmaniasis from Algeria, Tunisia, and southern France. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algeria
Share to Antiprotozoal Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leishmania infantum

Share to Leishmania major

Share to Leishmaniasis, Cutaneous

Share to Leishmaniasis, Visceral

Share to Organometallic Compounds

Share to Parasitic Sensitivity Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 24913173
DOI: 10.1128/AAC.02521-13
PMCID: PMC4136049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.PMID 24913173Read ↗

Antimony resistance and gene expression in Leishmania : spotlight on molecular and proteomic aspectsSemantic proximity Read ↗

Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profilingSemantic proximity Read ↗

Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovaniSemantic proximity Read ↗

Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapiesSemantic proximity Read ↗

Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review.Semantic proximity Read ↗

Epidemiological Insights: Unraveling Drug Resistance in Leishmania Species through Comprehensive StudiesSemantic proximity Read ↗

Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transportSemantic proximity Read ↗

Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin BSemantic proximity Read ↗

Drug resistance analysis by next generation sequencing in Leishmania.Semantic proximity Read ↗

Insights on genomic profiles of drug resistance and virulence in a cohort of <i>Leishmania infantum</i> isolates from the Mediterranean areaSemantic proximity Read ↗

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.Semantic proximity Read ↗

(Post-) Genomic approaches to tackle drug resistance in Leishmania.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.